TITLE

TEVA V. SANDOZ: THE SUPREME COURT REJECTS MILLENNIAL FEDERAL CIRCUIT'S "CLEARLY ERRONEOUS" REVIEW STANDARD

AUTHOR(S)
Havens, Cassandra E.
PUB. DATE
January 2016
SOURCE
Berkeley Technology Law Journal;2016 Special Issue, Vol. 31, p399
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the decision of the U.S. Supreme Court in the case Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. which established a new hybrid standard of review for patent claim construction decisions. It mentions that patent claim construction should be reviewed for clear error pursuant to Federal Rule of Civil Procedure 52. It also mentions that the U.S. Supreme Court in the case Markman v. Westview Instruments, Inc. on patent infringement.
ACCESSION #
120485574

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics